Related Experiment Video
Updated: Aug 13, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Bioavailability and disposition kinetics of rifampicin capsules
1Department of Physiology and Pharmacology, University of Agriculture, Faisalabad, Pakistan.
Abstract:
Different drug manufactures claim better quality and bioavailability of the similar dosage from of a drug product. In view of this, bioequivalence on the basis of bioavailability and disposition kinetics of rifampicin capsules marketed under the brand names of Rifadin, Rifapin and Rimactane were investigated in normal human volunteers. Each drug was given orally and blood levels of active rifampicin at different times were measured by a microbiological assay procedure. The studies revealed that the absorption kinetics, bioavailability and disposition kinetics of three brands of rifampicin did not differ from each other significantly in human volunteers.
Related Concept Videos
Bioavailability: Influencing Factors
Factors Influencing Bioavailability: First-Pass Elimination
Modified-Release Drug Delivery Systems: Bioavailability
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Bioavailability: Overview
Bioavailability: Overview